ASE·Healthcare·$95M·#221 / 520 in Healthcare
NRXS Neuraxis, Inc.
49SPECULATIVE
CATEGORY BREAKDOWN
GROWTH53
QUALITY60
STABILITY48
VALUATION3
GOVERNANCE60
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+32.9%
53
> 50% strong
Gross Margin
Revenue retained after direct costs
84.2%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
9 months
26
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
12.3%
90
< 25% strong
Price / Sales
Market cap relative to trailing revenue
26.7x
3
< 3x strong
Rule of 40
Growth rate plus operating margin
-186
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
23.0%
89
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+59.4%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE NRXS WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when NRXS's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.